Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can diet and lifestyle shape life after a heart attack? a large study investigates

NCT ID NCT03192410

Knowledge-focused Sponsor: Wageningen University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 19, 2026 · Last updated Aug 20, 2026 · Updated 1 time

Summary

This study follows over 4,800 Dutch heart attack survivors aged 60-80 to understand how diet, lifestyle, blood markers, and genetics relate to their long-term health. Researchers are tracking cardiovascular deaths, major heart events, and other conditions like diabetes and cognitive decline. By analyzing questionnaires, physical exams, and blood samples, the study aims to uncover factors that may influence outcomes after a heart attack.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Dietary intake, lifestyle factors, blood biomarkers, health status, and DNA (genetic markers)
What this could lead to
If successful, this study could reveal how diet, lifestyle, and genetics influence long-term health after a heart attack, potentially guiding future prevention strategies.
What could go wrong
This is an observational study, so it cannot prove cause and effect. Results may be influenced by unmeasured factors, and findings may not apply to all heart attack survivors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

4,837 people

The number who actually took part.

Started

Apr 2002

Expected to finish

Jan 2040

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

4837 patients (78% male) with a history of myocardial infarction up to 10 y before entry into the study, recruited from 32 hospitals in the Netherlands.

Ages

60 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

The Alpha Omega Cohort is a prospective cohort study. The cohort originated from the Alpha Omega Trial, a 40-month intervention study of low doses of n-3 fatty acids (in margarine spreads) and cardiovascular events (NCT00127452). The in/exclusion criteria were defined for the Alpha Omega Trial. Inclusion criteria: * Men and women * Aged 60 through 80 y * Verified clinically diagnosed myocardial infarction up to 10 y before entry into the study * Written informed consent Exclusion criteria: * Living in a nursing home or other institution * Participation in another scientific study * Habitual margarine intake \< 10 g per day * Habitual fish intake \> 150 g per day * Habitual alcohol intake \> 6 drinks per day * Use of fish oil capsules or other supplements containing omega-3 fatty acids * Presence of cancer with \< 1 y of life expectancy * Cognitive impairment, as indicated by the Mini Mental State Examination (score \<= 21) * Unintended weight loss \> 5 kg in the past year * Lack of facilities for cooled margarine storage at home * Inability or unwillingness to comply with study procedures

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiovascular diseases are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cardiovascular disorder Cognitive Dysfunction myocardial infarction Psychological Well-Being type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiovascular diseases Cognitive decline Kidney function Mental well-being Mortality Type 2 diabetes mellitus

Contacts and locations

Locations

  • Wageningen University, Division of Human Nutrition

    Wageningen, 6700 AA, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.